Recombinant Methylobacterium radiotolerans Large-conductance mechanosensitive channel (mscL)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, but this can be adjusted to customer specifications.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
mscL; Mrad2831_1030; Large-conductance mechanosensitive channel
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-139
Protein Length
full length protein
Species
Methylobacterium radiotolerans (strain ATCC 27329 / DSM 1819 / JCM 2831)
Target Names
mscL
Target Protein Sequence
MLEEFKKFALRGNVVDLAVGVIIGAAFGAIVNSAVQDIFMPVIGAITGGLDFSNYYIPLS SKVQSGLPYVDAKKQGAVIGYGQFLTLTLNFAIVAFVLFLVIRAMNRLQLAETKKPDEVP ADVKLLSEIRDILATKPRV
Uniprot No.

Target Background

Function
A mechanosensitive channel that opens in response to membrane lipid bilayer stretch forces. It may play a role in regulating cellular osmotic pressure changes.
Database Links
Protein Families
MscL family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the Methylobacterium radiotolerans MscL protein and what is its significance in mechanosensation research?

The Methylobacterium radiotolerans Large-conductance mechanosensitive channel (MscL) is a bacterial membrane protein that responds to mechanical stress by opening a large pore. This channel was among the first exclusively mechanosensitive ion channels identified and serves as a model system for studying mechanotransduction . The MscL protein from M. radiotolerans consists of 139 amino acids and functions as a safety valve that protects bacterial cells from osmotic shock by allowing rapid efflux of cytoplasmic solutes when membrane tension increases.

The significance of this channel in research stems from its pure mechanosensitivity and versatility for genetic modification, making it an excellent tool for developing mechano-genetic approaches in various biological systems . Unlike other channels that might respond to multiple stimuli, MscL responds specifically to membrane tension, providing a clean experimental system to study mechanotransduction mechanisms.

How does the structure of M. radiotolerans MscL compare to other bacterial MscL proteins?

The M. radiotolerans MscL protein consists of 139 amino acids with a sequence that contains characteristic transmembrane domains and cytoplasmic regions typical of bacterial mechanosensitive channels . The full amino acid sequence is:

MLEEFKKFALRGNVVDLAVGVIIGAAFGAIVNSAVQDIFMPVIGAITGGLDFSNYYIPLSSKVQSGLPYVDAKKQGAVIGYGQFLTLTLNFAIVAFVLFLVIRAMNRLQLAETKKPDEVPADVKLLSEIRDILATKPRV

While sharing structural homology with other bacterial MscL proteins, such as those from E. coli and Mycobacterium tuberculosis, the M. radiotolerans MscL has specific sequence variations that may contribute to its unique gating properties and tension sensitivity. These structural features make it potentially valuable for comparative studies of mechanosensation mechanisms across different bacterial species.

How can recombinant M. radiotolerans MscL be used for mechano-sensitization of mammalian neuronal networks?

Recombinant M. radiotolerans MscL can be heterologously expressed in mammalian neurons to create mechano-sensitized neuronal networks. This approach involves:

  • Genetic modification: Engineering the MscL protein for optimal expression in mammalian systems, including codon optimization and addition of appropriate trafficking signals.

  • Transfection/transduction: Delivering the engineered MscL gene into neuronal cultures using viral vectors or other transfection methods.

  • Validation: Confirming functional expression through patch-clamp recordings upon application of calibrated suction pressures to verify mechanosensitivity .

Research has demonstrated that neurons expressing engineered MscL develop normal networks with proper survival rates, synaptic connections, and spontaneous activity patterns. The advantage of this approach is that it provides a non-invasive method to stimulate specific neuronal populations through mechanical stimuli, which can penetrate intact brain tissue more effectively than other stimulation vectors . This technology represents a promising tool for developing new cell-type-specific stimulation approaches for both research and potential therapeutic applications.

What controls should be included when studying the effects of MscL expression in neuronal cultures?

  • Non-transfected controls: Neuronal cultures without MscL expression should be maintained under identical conditions to assess baseline mechanosensitivity and network activity.

  • Network development validation: Quantification of cell survival, number of synaptic puncta, and spontaneous network activity should be compared between MscL-expressing and control neurons .

  • Specificity controls: Expressing mechanosensitivity-deficient MscL mutants to confirm that observed effects are specifically due to the mechanosensitive properties of the channel rather than off-target effects of protein expression.

  • Patch-clamp validation: Electrophysiological recordings should demonstrate that channel activity occurs specifically in response to mechanical stimuli at expected pressure thresholds .

These controls are essential to verify that the MscL channel is functionally expressed, that neurons remain healthy, and that network properties are maintained despite the introduction of this bacterial protein into mammalian cells.

What are the optimal storage and reconstitution conditions for recombinant M. radiotolerans MscL protein?

The optimal storage and reconstitution of recombinant M. radiotolerans MscL protein requires careful handling to maintain functionality:

Storage conditions:

  • Store lyophilized protein at -20°C/-80°C upon receipt

  • Aliquot the reconstituted protein to avoid repeated freeze-thaw cycles

  • For working aliquots, store at 4°C for up to one week

Reconstitution protocol:

  • Briefly centrifuge the vial prior to opening to bring contents to the bottom

  • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Add glycerol to a final concentration of 5-50% (50% is recommended) for long-term storage

  • Store reconstituted aliquots at -20°C/-80°C

Repeated freeze-thaw cycles should be avoided as they can denature the protein and compromise its functionality. The storage buffer (Tris/PBS-based buffer with 6% Trehalose, pH 8.0) helps maintain protein stability during storage . Proper reconstitution and storage are critical for experiments requiring functional MscL channels, particularly for incorporation into artificial membranes or liposomes.

What expression systems are most effective for producing functional recombinant M. radiotolerans MscL?

The production of functional recombinant M. radiotolerans MscL protein has been successfully achieved using E. coli expression systems . This bacterial expression platform offers several advantages:

  • High yield: E. coli can produce substantial quantities of recombinant membrane proteins.

  • Post-translational modifications: The minimal post-translational modifications required by bacterial MscL proteins align well with E. coli's capabilities.

  • His-tagging: N-terminal His-tag addition facilitates purification while maintaining channel functionality .

The commercially available recombinant full-length M. radiotolerans MscL protein (amino acids 1-139) is expressed in E. coli with an N-terminal His-tag . This approach yields protein with greater than 90% purity as determined by SDS-PAGE.

For researchers developing their own expression systems, optimizing growth conditions, induction parameters, and membrane extraction protocols is essential for obtaining functional MscL protein. Alternative expression systems, such as cell-free synthesis or insect cell expression, may be explored for specific applications requiring different post-translational modifications or folding environments.

How can M. radiotolerans MscL be engineered for stimulus-specific activation in neuronal applications?

Engineering M. radiotolerans MscL for stimulus-specific activation in neuronal applications involves sophisticated genetic modifications:

  • Light-sensitive MscL variants: Incorporation of photoswitchable compounds or fusion with light-sensitive domains can create optically-controlled MscL channels, enabling combined optogenetic and mechanosensitive approaches.

  • Tension-sensitivity tuning: Strategic mutations in transmembrane domains can alter the tension threshold required for channel opening, allowing for calibrated responses to different mechanical force intensities.

  • Chemical/ligand gating: Engineering MscL to respond to specific chemical ligands by introducing binding sites that induce conformational changes leading to channel opening.

The versatility of MscL for genetic modification makes it an excellent platform for developing stimulus-specific activation mechanisms . These engineered channels could enable precise spatial and temporal control of neuronal activity through non-invasive mechanical stimuli, potentially advancing both neuroscience research and therapeutic neurostimulation approaches. The pure mechanosensitivity of the engineered MscL, combined with its extensive genetic modification library, represents a versatile tool for developing advanced mechano-genetic techniques.

What are the potential mechanisms of heavy metal interactions with M. radiotolerans MscL and their implications for channel function?

The interaction between heavy metals and M. radiotolerans MscL represents an intriguing research area with implications for both channel function and potential biotechnological applications:

M. radiotolerans demonstrates significant tolerance to heavy metals, with maximum tolerance concentrations (MTC) reported at:

  • Zinc: 15 mM

  • Copper: 4 mM

  • Nickel: 12 mM

Transmission electron microscopy (TEM) analysis has shown that M. radiotolerans can accumulate metals intracellularly . This accumulation may influence MscL function through several potential mechanisms:

  • Direct binding: Heavy metals may directly interact with cytoplasmic or transmembrane domains of MscL, potentially affecting gating kinetics or channel conductance.

  • Membrane reorganization: Heavy metal stress could alter bacterial membrane composition or tension, indirectly affecting MscL activation thresholds.

  • Protein expression regulation: Metal stress may upregulate or downregulate MscL expression as part of the bacterial stress response.

The M. radiotolerans genome contains various heavy metal resistance proteins, including copper resistance gene A and TonB-dependent transporters involved in metal transport . Understanding how these resistance mechanisms interact with MscL function could provide insights into channel modulation under stress conditions and potential applications in bioremediation systems utilizing mechanosensitive channels.

How does the electrophysiological signature of M. radiotolerans MscL compare to other bacterial mechanosensitive channels when expressed in mammalian cells?

The electrophysiological signature of M. radiotolerans MscL in mammalian cells reveals distinct properties compared to other bacterial mechanosensitive channels:

  • Conductance profile: M. radiotolerans MscL exhibits large conductance (approximately 3 nS) characteristic of bacterial MscL channels, significantly larger than mammalian mechanosensitive channels.

  • Pressure activation thresholds: When expressed in mammalian cells and measured via patch-clamp with calibrated suction pressures, MscL activation requires specific tension thresholds that can differ from other bacterial MscL variants .

  • Gating kinetics: The opening and closing rates of M. radiotolerans MscL may exhibit unique patterns that distinguish it from other bacterial mechanosensitive channels.

To properly characterize these signatures, patch-clamp recordings must be performed on mammalian cells expressing the channel, using protocols that apply precisely calibrated negative pressures to excised membrane patches. The distinct electrophysiological properties of M. radiotolerans MscL make it valuable for comparative studies of mechanotransduction mechanisms and for developing specialized tools for neuronal stimulation where specific conductance properties are desired.

What are the considerations for using M. radiotolerans MscL in developing potential therapeutic neurostimulation technologies?

Developing therapeutic neurostimulation technologies using M. radiotolerans MscL requires addressing several critical considerations:

  • Immune response: As a bacterial protein, MscL may trigger immune responses when introduced into mammalian systems. Strategies to minimize immunogenicity, such as protein engineering or encapsulation, must be explored.

  • Expression control: Developing tightly regulated expression systems to ensure appropriate levels of MscL in target neuronal populations is crucial for safety and efficacy.

  • Delivery methods: Efficient delivery of the MscL gene to specific neuronal populations requires optimized viral vectors or non-viral delivery systems with appropriate cell-type specificity.

  • Mechanical stimulus delivery: Engineering practical, non-invasive methods to deliver precise mechanical stimuli to MscL-expressing neurons in deep brain structures remains a significant challenge .

  • Safety profiling: Comprehensive evaluation of potential adverse effects from long-term MscL expression in neurons, including effects on cell viability, synaptic function, and network activity, is essential.

How might clinical isolates of M. radiotolerans affect patients with implanted neurostimulation devices containing recombinant MscL?

The potential interaction between clinical M. radiotolerans isolates and implanted neurostimulation devices containing recombinant MscL presents a complex biosafety consideration:

M. radiotolerans is an environmental bacterium occasionally found in clinical settings, particularly in:

  • Immunocompromised patients

  • Individuals with intravascular devices

  • Patients undergoing hemodialysis

Potential concerns include:

  • Genetic exchange: Theoretical possibility of horizontal gene transfer between native M. radiotolerans bacteria and engineered cells in neurostimulation devices, potentially altering device function.

  • Biofilm formation: M. radiotolerans may form biofilms on device surfaces, potentially interfering with mechanical stimulus delivery or electrode function.

  • Immune response modulation: Presence of M. radiotolerans could alter local immune responses around implanted devices containing recombinant MscL constructs.

  • Antimicrobial considerations: M. radiotolerans exhibits reduced susceptibility to many commonly used antibiotics, including broad resistance to β-lactams, making infection management challenging .

Though M. radiotolerans bacteremia is rare, with few reported cases in the literature , device design and patient monitoring protocols should account for the potential presence of this organism, particularly in immunocompromised individuals receiving neurostimulation therapies based on recombinant MscL technology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.